NCT04593147View on ClinicalTrials.gov

Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants

NACompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

November 9, 2021

Study Completion Date

November 9, 2021

Conditions
Infant Development
Interventions
OTHER

BBN

BBN to be fed as the sole source of nutrition for 16 weeks to healthy term infants for 16 weeks.

OTHER

Brand

Brand to be fed as the sole source of nutrition for 16 weeks to healthy term infants for 16 weeks

Trial Locations (1)

33613

PAS Research, Tampa

Sponsors

Collaborators (1)

Paidion Research, Inc.
All Listed Sponsors
collaborator

Paidion Research, Inc.

INDUSTRY

lead

Building Block Nutritionals, LLC

INDUSTRY

NCT04593147 - Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants | Biotech Hunter | Biotech Hunter